Jyong Biotech Ltd. Ordinary Shares (MENS) — Net Asset Momentum
Jyong Biotech Ltd. Ordinary Shares (MENS) recorded a net asset momentum of 31.8% as of December 2025, with net assets of $-24.91 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Jyong Biotech Ltd. Ordinary Shares for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Jyong Biotech Ltd. Ordinary Shares Net Asset Momentum (2020–2025)
This chart tracks Jyong Biotech Ltd. Ordinary Shares's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +31.8%, with net assets of $-24.91 Million USD as of December 2025. For live market cap and overall valuation, see MENS company net worth.
Annual Net Asset History for Jyong Biotech Ltd. Ordinary Shares (2020–2025)
The table below shows the complete annual net asset history for Jyong Biotech Ltd. Ordinary Shares from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. See Jyong Biotech Ltd. Ordinary Shares (MENS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-24.91 Million | $20.78 Million | $45.68 Million | ▲ +31.8% |
| 2024 | $-36.52 Million | $6.37 Million | $42.88 Million | ▼ -7.2% |
| 2023 | $-34.07 Million | $8.25 Million | $42.32 Million | ▼ -15.0% |
| 2022 | $-29.63 Million | $8.74 Million | $38.38 Million | ▼ -27.0% |
| 2021 | $-23.32 Million | $9.43 Million | $32.76 Million | ▼ -21.5% |
| 2020 | $-19.20 Million | $12.84 Million | $32.05 Million | — |